Regenerative medicine and cell therapy industry in 2011
At the end of the year I’d like to overview the most notable events in cell therapy and regenerative medicine industry. What made the headlines in mass media? What events were highly discussed in...
View ArticleClik here to view.
Public cell therapy and stem cell companies in 2011
Today, I’d like to look at how well public cell therapy and stem cell companies were doing on the market in 2011. By analyzing data, available for public, we can learn about trust and investor...
View Article10 companies to watch in 2012
2011 was very interesting year for cell therapy industry. We’re expecting even more exciting news this year. Today I’d like to overview some companies, which, in my opinion, could be worth watching in...
View ArticleClik here to view.
Stem cell therapeutic products on the market
Updated on Mar. 6, 2012 Last year I wrote about some regenerative medicine and cell therapy products on the market. You can find updated list here. But what is the value of stem cell products among...
View ArticleStem cell therapeutic products on the market – An update 1
Based on recent discussions, I updated the list of stem cell therapeutic products available on the market worldwide. Update: 1. Added one more product – AlloStem (AlloSource) 2. Market regulation for...
View ArticleClik here to view.
Trends in regenerative medicine industry – from 2007 to 2011
New report about a progress in regenerative medicine industry was just published online in Tissue Engineering Part B. This is a detailed update to 2008 Lysaght’s report. The report contains a lot of...
View ArticleAlliance for Regenerative Medicine’s 2012 Report
Alliance for Regenerative Medicine has published 2012 Industry Report and made it available for the public. It’s interesting and informative report. I’d encourage you to read it. A quick snapshot and...
View ArticleClik here to view.
Success of cell therapy producs after approval
Right now, each approval of cell therapy product on the market we’re cheering by “Wow!”. Maybe 5 years from now, we would say “so what?”. The recent example – Prochymal approval by Health Canada for...
View ArticleNotable market approvals in 2012
This year is very interesting for RegenMed and cell therapy industry. There were a number of notable market approvals, including stem cell, gene and tissue engineered products. In order to keep track...
View ArticleRegenerative medicine and cell therapy industry in 2012
As usual, at the end of the year, I overview the most interesting and important events in cell therapy and Regen industry. The list of top 10 events reflects solely my opinion. 1. Debate on regulation...
View ArticleCell therapy and Regen industry – some expectations from 2013
New 2013 year predicted to be a good and very interesting for cell therapy and Regen industry. I’m going to highlight at least few reasons why it will be very exciting year for the field. 1. Upcoming...
View ArticleRegenerative medicine industry 2013 report
The Alliance for Regenerative Medicine (ARM) just issued an Annual 2013 Report. It’s absolutely worth a look/ download and read! ARM is US-based advocacy organization, aimed to promote clinical...
View ArticlePublic versus private cell therapy and stem cell companies
Cell therapy and RegenMed industry has a great variety of public and private companies. Currently, the overall value of public companies is much lower then private. If we look at cell therapy field,...
View ArticleOsiris boom and definition of stem cell product
Today US-based “stem cell therapeutic” company Osiris released a data from clinical trial, which assess their product Grafix in diabetic leg wounds. It was the biggest shake in the “stem cell...
View ArticleBig Pharma acquires stem cell, RegenMed and cell therapy assets
While ago, I’ve written about relationships between Pharma/ Biotech and cell therapy industry. Few years back, Pharma still was curious and “sniffing air” around, but what about now? This year, I’ve...
View Article10 new companies to watch
I’ve decided to do an experiment and overview some new companies that I like. If you like the idea, I can do it 1-2 times per year. You can suggest new cool companies to me. In order to pick companies...
View ArticleRegenMed, stem cell and cell therapy industry in 2013
At the end of the year, I overview the most interesting and important events in stem cell/ RegenMed/ cell therapy industry. This year I’d like to focus on trends, rather than separate events. Here is...
View ArticleCell therapy industry – expectations for 2014
Today, I’d like to highlight few trends and events, which will or could happen this year in cell therapy industry field. I don’t like to predict, so, I’d rather list some expectations. The field is...
View Article10 new companies to watch – part 2
5 months ago I’ve picked and brought to your attention a list of new interesting companies. In the last few months, I’ve learned more companies, and today, I’m sharing the new list of 10 with you. As...
View ArticleStem cell therapeutic products on the market – update 2
I continue to monitor “stem cell therapeutic products” on a market worldwide. These products could be approved by regulatory agencies or claimed (by manufacturers) as “tissue products” without...
View Article
